The Chase Freedom Unlimited card has a 15-month 0% intro APR that allows you to pay off your next big purchase over time with no interest. Select reviews all the benefits of the card so you can decide if it’s right for you.
The stock market passed a key test in the charts, but another threat looms
The S&P 500 dodged a negative chart signal and found support around a key level, but it is interest rates that will drive the index in the near term.
The explosion of risky zero-day options could worsen market shocks, JPMorgan says
JPMorgan said zero-day-to-expiration option could exaggerate market declines to as much as 20% during market turmoil.
Marlboro maker Altria agrees to buy e-cigarette startup NJOY for nearly $2.8 billion
Altria’s deal to buy NJOY comes after the Marlboro maker exited its position in Juul Labs.
The pros and cons of refinancing your home
If you’re thinking of refinancing your home, here’s what to consider, according to a community loan officer.
Morgan Stanley’s Jonas calls Ferrari his top pick, replacing Tesla
The firm’s new price target implies the stock could rally 14%.
Toblerone chocolate to cut iconic Matterhorn logo from packaging due to ‘Swissness’ laws
Switzerland requires milk-based products promoting themselves as Swiss to be made entirely within the country.
Saudi Arabia drops $5 billion in Turkey’s central bank to help its struggling economy
The news comes as Turkey struggles with an economy battered by years of high inflation and a recent series of devastating earthquakes.
Here’s what makes cybersecurity giant Palo Alto Networks tick and why we like the stock so much
An in-depth look at Palo Alto Networks’ various business lines and its finances backs up our optimism in the Club holding.
FDA will review Eisai and Biogen’s Alzheimer’s treatment Leqembi with decision on full approval expected in early July
Medicare has agreed to provide broader coverage once Leqembi receives full FDA approval.